US Patent Issued to INTERVET on March 17 for "Caninized antibodies to canine interleukin-31 receptor alpha" (Nebraska, New Jersey, California Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,310, issued on March 17, was assigned to INTERVET INC. (Rahway, N.J.).

"Caninized antibodies to canine interleukin-31 receptor alpha" was invented by Mohamad Morsey (Omaha, Neb.), Yuanzheng Zhang (Somerset, N.J.) and Anasuya Saha (Fremont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides caninized rat antibodies to canine IL-31 receptor alpha that have a high binding affinity for canine IL-31 receptor alpha, and that can block the binding of canine IL-31 to canine IL-31 receptor alpha. The present invention further provides the use of the antibodies for the treatment of atopic dermatitis in dogs."

The patent was...